Literature DB >> 9038165

The promoters for human and monkey poliovirus receptors. Requirements for basic and cell type-specific activity.

D Solecki1, S Schwarz, E Wimmer, M Lipp, G Bernhardt.   

Abstract

The cellular receptors for poliovirus (PVR) are glycoproteins belonging to the immunoglobulin superfamily. Functional receptors for poliovirus are only expressed by primates; known rodent homologues lack the ability to bind virus due to amino acid differences. Human poliovirus infections are targeted to the gastrointestinal tract and, rarely, to motor neurons in the central nervous system. Available evidence suggests that poliovirus uses only one cellular receptor, implying that the tissue tropism of poliovirus is likely to be related to the expression of the human PVR (hPVR). However, low levels of expression of hPVR-specific mRNAs can be detected in many human tissues other than the apparent target cells. The nonpathogenic function of hPVR is unknown. For a study of the transcriptional control of hPVR expression, we have isolated and characterized the promoter of the hPVR gene. Deletion analysis defined an approximately 280 base pair minimal promoter fragment that: 1) lacks TATA- and CAAT-like elements, 2) is distinguished by a high GC content, and 3) promotes transcription at multiple start sites. The pattern of activity caused by transfection of serial 5'- and 3'-promoter deletions is almost identical in HEp2, HeLa, COS-1, and mouse L929 cells, indicating a similar transcriptional regulation of the hPVR promoter in these cell lines. However, on transfection of Raji cells, a Burkitt's lymphoma cell line harboring a transcriptionally inactive hPVR gene, all promoter reporter constructs tested exerted only residual activity. These results suggest that the cis-element(s) governing cell type-specific hPVR expression resides in the minimal promoter region. We also report the sequences of the promoters of two monkey homologues to hPVR (AGMalpha1 and AGMalpha2). Transcripts encoding the monkey poliovirus receptors originate from a region analogous to that identified for hPVR transcripts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9038165     DOI: 10.1074/jbc.272.9.5579

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Transcriptional regulation of mouse delta-opioid receptor gene.

Authors:  H C Liu; J T Shen; L B Augustin; J L Ko; H H Loh
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

2.  Sp1 and Sp3 control constitutive expression of the human NHE2 promoter by interactions with the proximal promoter and the transcription initiation site.

Authors:  Ian Pearse; Ying X Zhu; Eleanor J Murray; Pradeep K Dudeja; Krishnamurthy Ramaswamy; Jaleh Malakooti
Journal:  Biochem J       Date:  2007-10-01       Impact factor: 3.857

3.  p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells.

Authors:  Alessandra Soriani; Cristiana Borrelli; Biancamaria Ricci; Rosa Molfetta; Alessandra Zingoni; Cinzia Fionda; Silvia Carnevale; Maria Pia Abruzzese; Maria Teresa Petrucci; Maria Rosaria Ricciardi; Giuseppe La Regina; Erica Di Cesare; Patrizia Lavia; Romano Silvestri; Rossella Paolini; Marco Cippitelli; Angela Santoni
Journal:  Oncoimmunology       Date:  2016-12-02       Impact factor: 8.110

4.  A host-specific, temperature-sensitive translation defect determines the attenuation phenotype of a human rhinovirus/poliovirus chimera, PV1(RIPO).

Authors:  Nusrat Jahan; Eckard Wimmer; Steffen Mueller
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

5.  Oncolytic poliovirus against malignant glioma.

Authors:  Christian Goetz; Elena Dobrikova; Mayya Shveygert; Mikhail Dobrikov; Matthias Gromeier
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

6.  Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.

Authors:  Vidyalakshmi Chandramohan; Jeffrey D Bryant; Hailan Piao; Stephen T Keir; Eric S Lipp; Michaela Lefaivre; Kathryn Perkinson; Darell D Bigner; Matthias Gromeier; Roger E McLendon
Journal:  Arch Pathol Lab Med       Date:  2017-08-22       Impact factor: 5.534

7.  Overexpression of the CD155 gene in human colorectal carcinoma.

Authors:  D Masson; A Jarry; B Baury; P Blanchardie; C Laboisse; P Lustenberger; M G Denis
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

8.  Phosphorylation of Oct-2 at sites located in the POU domain induces differential down-regulation of Oct-2 DNA-binding ability.

Authors:  V Pevzner; R Kraft; S Kostka; M Lipp
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

Review 9.  Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus.

Authors:  Julie K Pfeiffer
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

Review 10.  Recombinant Poliovirus for Cancer Immunotherapy.

Authors:  Matthias Gromeier; Smita K Nair
Journal:  Annu Rev Med       Date:  2018-01-29       Impact factor: 13.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.